xylometazoline – Xylen nasal drops 0.05% 10 ml


SKU: USUK462O3l Categories: ,


Latin name



Bottle of 10 ml.

Pharmacological action

Xylen – vasoconstrictor for local use in ENT practice.

Stimulates alpha adrenergic receptors, causes vasoconstriction, reduces swelling of the nasal mucosa and secretions, restores patency of the nasal passages, and facilitates nasal breathing.


Acute allergic rhinitis, sinusitis, hay fever, otitis media (to reduce swelling of the nasopharynx) preparing the patient for diagnostic procedures in the nasal passages.


Angle-closure glaucoma, atrophic rhinitis, arterial hypertension, tachycardia, severe atherosclerosis, hyperthyroidism, brain surgery (history), hypersensitivity to xylometazoline.

Use during pregnancy and lactation

During pregnancy and lactation, it should be used only after a careful assessment of the risk-benefit ratio for the mother and the fetus, it is not allowed to exceed the recommended doses.


1 ml drops contain:

Active ingredient:

xylometazoline hydrochloride – 0.0005 g


benzalkonium chloride (in terms of anhydrous),

disodium edetate (Trilon B),

potassium dihydrogen phosphate,

sodium hydrogen phosphate dodecahydrate,

sodium chloride,

purified water.

Dosage and administration

Adults and children over 6 years of age are given 1-2 drops of 0.1% xylometazoline solution in each nasal passage 2-3 times a day.

For infants and children up to 6 years of age, use a 0.05% solution of 1-2 drops in each nasal passage 1-2 times a day. Do not use the drug more than 3 times a day and no more than 3-5 days. Do not use the drug without a break for more than 3-5 days.

Side effects

With frequent and / or prolonged use: irritation of the mucosa, burning, tingling, sneezing, dry nasal mucosa, hypersecretion.

Rarely: swelling of the nasal mucosa (more often with prolonged use), palpitations, heart rhythm disturbances, increased blood pressure, headache, vomiting, sleep disturbances, and visual impairment.

With prolonged use in high doses: depressed.

Drug Interaction

Incompatible with monoamine oxidase (MAO) inhibitors and tricyclic antidepressants.


Symptoms: increased side effects.

Treatment: symptomatic under the supervision of a physician.

Storage conditions

In a dry, dark place.

Shelf suitability

3 Year


substances xylometazoline



nasal drops